FDA inspection
Axsome Therapeutics, Inc.: FDA inspection ending Feb 6, 2026
FDA inspection 1301534 · Voluntary Action Indicated (VAI) · New York, NY
Key facts
| Inspection ID | 1301534 |
|---|---|
| Firm | Axsome Therapeutics, Inc. |
| FEI number | 3018815311 |
| Address | 1 World Trade Ctr Fl 29 |
| City | New York |
| State | NY |
| ZIP | 10007 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Feb 6, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data